SIGNIFICANCE INC. ANNOUNCES ADDITION OF MELISSA HOUGHTON AS CHIEF GROWTH OFFICER
Houghton is a proven corporate growth and strategy leader with over 20 years of experience in business development and the Federal IT services industry. Over the course of her long career, Melissa has had an impressive track record of transforming small businesses into mid- and large-market competitors. She is coming to Significance after serving as Senior Vice President of Growth at Ventech. Prior to Ventech, she served as VP of Corporate Growth at Redhorse and VP of Business Growth at CGI Federal. She has a wealth of experience in emerging technologies, P&L management, new business development, and strategy as well as nurturing and finalizing JVs and M&A Integration. Prior to joining CGI, she was with SRA International in roles including Director of Capture Planning and Principal and Senior Business Integration Manager.
"We are thrilled to have Melissa join Significance and our executive leadership team. Her experience and proven success will be invaluable as we enter our next phase of growth" said Mary Ahern Snyder, President and Chief Executive Officer.
Houghton holds a Master of Public Management, and National Security from the University of Maryland and a BA, in Political Science from Dickinson College. Her Certifications include Project Management Professional (PMP); ITIL Foundations.
About Significance Inc.
Significance Inc. is designated an Economically-Disadvantaged Woman-Owned Small Business (EDWOSB) with offices in Old Town Alexandria, VA , and Annapolis, MD. Founded in 2014 by
View original content to download multimedia:https://www.prnewswire.com/news-releases/significance-inc-announces-addition-of-melissa-houghton-as-chief-growth-officer-302073739.html
SOURCE Significance, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Katten Expands Restructuring Practice with Addition of Genevieve Weiner
- MOBILE SUIT GUNDAM SEED FREEDOM ZERO Heads to New York Comic Con 2026 With Panel and Livestream
- Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share